Nevro, a Silicon Valley-based company, announced that it has received CE mark approval for its Senza Omnia Spinal Cord Stimulation (SCS) system for management of chronic pain. The device was FDA approved for chronic pain in November 2019.
Nevro touts its device as the first and only that is designed to deliver all frequencies from 2 to (Read more...)